[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Page 69133]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27486]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE


Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration; Lin 
Zhi International, Inc.

    By Notice dated May 14, 2013, and published in the Federal Register 
on May 22, 2013, 78 FR 30332, Lin Zhi International, Inc., 670 Almanor 
Avenue, Sunnyvale, California 94085, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxymethamphet- amine (MDMA)   I
 (7405).
Cocaine (9041).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
as bulk reagents for use in drug abuse testing.
    In reference to drug code 7370 the company plans to bulk 
manufacture a synthetic Tetrahydrocannabinol. No other activity for 
this drug code is authorized for this registration.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Lin Zhi International, Inc., to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Lin Zhi International, Inc., to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 
1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: November 4, 2013.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27486 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P